Bridges to Life

Chapter

Abstract

The future of aging and human life extension begins today, using presently available tools, but will be increasingly shaped and accelerated by ongoing breakthroughs in biotechnology, nanotechnology and artificial intelligence in the years ahead. These developing technologies should allow many to journey over what can be seen as three bridges to ever-improving life and health expectancy, such that some who survive as a result of “bridge one” may be able to benefit from “bridge two” and even from “bridge three.” We begin our perspective on the future of aging with a brief overview of a sampling of present approaches to life extension (“bridge one”) and then explain why biotechnology (“bridge two”) and nanotechnology plus artificial intelligence (“bridge three”) might allow many of us to benefit from remarkably extended lifespans in the future.

Keywords

Caloric Restriction Aerobic Exercise Genomic Testing Remain Life Expectancy Restricting Calorie 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. American College of Sports Medicine, ed. (2010) ACSM’s Resource manual for Guidelines for Exercise Testing and Prescription, Lippincott, Williams and Wilkins: Philadelphia, pp. 346–347, 513–514Google Scholar
  2. Ames BN, Elson-Schwab I, Silver EA (2002) High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms. Am J Clin Nutr 75:616–658PubMedGoogle Scholar
  3. Ames BN, Wakimoto P (2002) Are vitamin and mineral deficiencies a major cancer risk? Nat Rev Cancer 2:694–704PubMedCrossRefGoogle Scholar
  4. Angier N. Diet offers tantalizing clues to a long life. New York Times, April 17, 1990, sec. CGoogle Scholar
  5. Barger JL, Kayo T, Pugh TD, Prolla TA, Weindruch R (2008) Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart. Exp Gerontol 43:859–866PubMedCrossRefGoogle Scholar
  6. Baur JA, Pearson KJ, Price, NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair, DA (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337–342Google Scholar
  7. Berger TW, Ahuja A, Courellis SH, Deadwyler SA, Erinjippurath G, Gerhardt GA, Gholmieh G, Granacki JJ, Hampson R, Hasio MC, Lacoss J, Marmarelis VZ, Nasiatka P, Srinivasan V, Song D, Tanguay AR, Wills J (2005) Restoring lost cognitive function: hippocampal-cortical neural prostheses. IEEE Eng Med Biol 24:30–44CrossRefGoogle Scholar
  8. Blair SN, Kohl HW 3rd, Barlow CE, Gibbons LW (1989) Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 262:2395–2401PubMedCrossRefGoogle Scholar
  9. Blüher M, Kahn BB, Kahn CR (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299:572–574PubMedCrossRefGoogle Scholar
  10. Botto LD, Yang Q (2000) 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862–877PubMedCrossRefGoogle Scholar
  11. Cadieu C, Kouh M, Pasupathy A, Connor C, Riesenhuber M, Poggio T (2007) A model of V4 shape selectivity and invariance. J Neurophysiol 98:1733–1750PubMedCrossRefGoogle Scholar
  12. Cerami A (1985) Hypothesis: glucose as a mediator of aging. J Am Geriatr Soc 33:626–634PubMedGoogle Scholar
  13. Church TS, Earnest CP, Wood KA, Kampert JB (2003) Reduction of C-reactive protein levels through use of a multivitamin. Am J Med 15(115):702–707CrossRefGoogle Scholar
  14. Davies K (2007) Computational Biology: Project Jim: Watson’s Genome Goes Public: 454 Baylor Scientists Present Jim Watson with His Personal Genome, Flaws, and All. BioIT-World, 6:5,16Google Scholar
  15. Desai TA (2003) MEMS-based technologies for cellular encapsulation: focus on nanopore biocapsules for diabetes mellitus therapy. Am J Drug Deliv 1:3–11CrossRefGoogle Scholar
  16. Deschenes MR (2004) Effects of aging on muscle fibre type and size. Sports Med 34:809–824PubMedCrossRefGoogle Scholar
  17. Dhahbi JM, Mote PL, Fahy GM, Spindler SR (2005) Identification of potential calorie restriction mimetics by microarray profiling. Physiol Genomics 23:343–350PubMedCrossRefGoogle Scholar
  18. Dobson A, DaVanzo J, Consunji M, Gilani J, McMahon P, Sen N, Preston B (2004) A Study of the Cost Effects of Daily Multivitamins for Older Adults. The Lewin Group: Falls Church.Google Scholar
  19. Duncan, DE (2002) DNA as destiny. Wired 10:183Google Scholar
  20. Eto M, Watanabe K, Chonan N, Ishii K (1988) Familial hypercholesterolemia and apolipoprotein E4. Atherosclerosis. 72:123–128PubMedCrossRefGoogle Scholar
  21. Facchini A, Haaijman JJ, Labo G (eds) (1986) Immunoregulation in Aging. EURAGE: Rijswijk 53–61Google Scholar
  22. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer’s disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349–1356PubMedCrossRefGoogle Scholar
  23. Ferrari CK, Torres EA (2003) Biochemical pharmacology of functional foods and prevention of chronic diseases of aging. Biomed Pharmacother 57:251–260PubMedCrossRefGoogle Scholar
  24. Friedman DA, Lukiw WJ, Hill JM (2007) Apolipoprotein E ɛ4 Offers Protection Against Age-Related Macular Degeneration. Med Hypotheses 68(5):1047–1055PubMedCrossRefGoogle Scholar
  25. Hamdi HK, Keney C (2003) Age-Related Macular Degeneration: A New Viewpoint. Frontiers in Bioscience 8:e305–e314PubMedCrossRefGoogle Scholar
  26. Harrison SA, Ramrakhiani S, Brunt EM, Anbari MA, Cortese C, Bacon BR (2003) Orlistat in the treatment of NASH: a case series. Am J Gastroenterol 98:926–930PubMedCrossRefGoogle Scholar
  27. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC (2003) Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Ann Rev Med 54:131–152PubMedCrossRefGoogle Scholar
  28. Kahn C (1990) His theory is simple: eat less, live longer. A lot longer. Longevity 2 [Oct]:60–62, 64, 66Google Scholar
  29. Kamboh R (1995) Apolipoprotein E polymorphism and susceptibility to Alzheimer’s disease. Hum Biol 67:195–215PubMedGoogle Scholar
  30. Kardaun JW, White L, Resnick HE, Petrovitch H, Marcovina SM, Saunders AM, Foley DJ, Havlik RJ (2000) Genotypes and phenotypes for apolipoprotein E and Alzheimer disease in the Honolulu-Asia aging study. Clin Chem 46:1548–1554PubMedGoogle Scholar
  31. Koizumi A, Weindruch R, Walford RL (1987) Influences of dietary restriction and age on liver enzyme activities and lipid peroxidation in mice. J Nutr 117:361–367PubMedGoogle Scholar
  32. Kris-Etherton PM, Harris WS, Appel LJ for the Nutrition Committee (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:2747–2757PubMedCrossRefGoogle Scholar
  33. Kurzweil R (2005) The Singularity is Near: When Humans Transcend Biology. Viking, New York, pp. 491–496Google Scholar
  34. Kurzweil R, Grossman T (2004) Fantastic Voyage: Live Long Enough To Live Forever. Rodale, New YorkGoogle Scholar
  35. Kurzweil R, Grossman T (2009) Transcend: Nine Steps to Living Well Forever. Rodale, New YorkGoogle Scholar
  36. Lancaster JM (1997) BRCA 1 and 2—A Genetic Link to Familial Breast and Ovarian Cancer. Medscape Women’s Health 2: 7PubMedGoogle Scholar
  37. Lane MA, Mattison J, Ingram DK, Roth GS (2002) Caloric restriction and aging in primates: relevance to humans and possible CR mimetics. Microsc Res Tech 59:335–338PubMedCrossRefGoogle Scholar
  38. Lee IM (2003) Physical activity in women: how much is good enough? JAMA 290:1377–1378PubMedCrossRefGoogle Scholar
  39. Lee JKT, Sagel SS, Stanley RJ, Heiken JP (2005) Computed Body Tomography with MRI Correlation, 2nd Ed. Lippincott Williams & Wilkins, New YorkGoogle Scholar
  40. Li X, Du Y, Huang X (2003) Association of apoliproprotein E gene polymorphism with essential hypertension and its complications. Clin Exp Med 2:175–179PubMedCrossRefGoogle Scholar
  41. Licastro F, Weindruch R, Davis LJ, Walford RL (1988) Effect of dietary restriction upon the age-associated decline of lymphocyte DNA repair activity in mice. AGE 11:48–52CrossRefGoogle Scholar
  42. Liem AH, Jukema JW, van Veldhuisen DJ (2003) Secondary prevention in coronary heart disease patients with low HDL: what options do we have? Int J Cardiol 90:15–21PubMedCrossRefGoogle Scholar
  43. Markram H (2006) The blue brain project. Nat Rev Neurosci 7:153–160PubMedCrossRefGoogle Scholar
  44. McGinnis JM, Foege WH (1993) Actual causes of death in the United States. JAMA 270:207–212CrossRefGoogle Scholar
  45. Medina JF, Garcia KS, Nores WL, Taylor NM, Mauk MD (2000) Timing mechanisms in the cerebellum: testing predictions of a large-scale computer simulation. J Neurosci 20: 5516–5525PubMedGoogle Scholar
  46. Myers RH, Schaefer EJ, Wilson PW, D’Agostino R, Ordovas JM, Espino A, Au R, White RF, Knoefel JE, Cobb JL, McNulty KA, Beiser A, Wolf PA (1996) Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology 46:673–677PubMedCrossRefGoogle Scholar
  47. Prescott JH, Lipka S, Baldwin S, Sheppard NF Jr, Maloney JM, Coppeta J, Yomtov B, Staples MA, Santini JT Jr (2006) Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device. Nat Biotechnol 24:437–438PubMedCrossRefGoogle Scholar
  48. Reiser MF, Becker CR, Nikolaou K, Glazer G (2008) Multislice CT. Springer, Berlin, Heidelberg, New YorkGoogle Scholar
  49. Retz W, Gsell W, Munch G, Rosler M, Riederer P (1998) Free radicals in Alzheimer’s disease. J Neural Transm Suppl 54:221–236PubMedGoogle Scholar
  50. Riesenhuber M, Poggio T (2002) Neural mechanisms of object recognition. Curr Opin Neurobiol 12:162–168PubMedCrossRefGoogle Scholar
  51. Robitaille P-MLAM, Abduljalil AM, Kangarlu A (2000) Ultra high resolution imaging of the human head at 8 Tesla: 2 K × 2 K for Y2K. J Comp Assist Tomogr 24:2–8CrossRefGoogle Scholar
  52. Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO (2008) APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer’s disease; a case control study from central Norway. BMC Neurol Apr 16;8:9CrossRefGoogle Scholar
  53. Singh PP, Singh M, Mastana SS (2002) Genetic variation of apolipoproteins in North Indians. Hum Biol 74:673–682PubMedCrossRefGoogle Scholar
  54. Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C, van Duijn CM (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 55: 964–968PubMedCrossRefGoogle Scholar
  55. Trajtenberg M (1990) Economic Analysis of Product Innovation: The Case of CT Scanners. Harvard University Press, CambridgeGoogle Scholar
  56. Watts L (2003) Visualizing complexity in the brain. In: Fogel D, Robinson C, (eds) Computational Intelligence: The Experts Speak. IEEE Press/Wiley, Hoboken, pp. 45–56; http://www.lloydwatts.com/wcci.pdf
  57. Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, McGuire A, He W, Chen YJ, Makhijani V, Roth GT, Gomes X, Tartaro K, Niazi F, Turcotte CL, Irzyk GP, Lupski JR, Chinault C, Song XZ, Liu Y, Yuan Y, Nazareth L, Qin X, Muzny DM, Margulies M, Weinstock GM, Gibbs RA, Rothberg JM (2008) The complete genome of an individual by massively parallel DNA sequencing. Nature 452:872–876PubMedCrossRefGoogle Scholar
  58. Yeşin KB, Vollmers K, Nelson BJ (2006) Modeling and control of untethered biomicrorobots in a fluidic environment using electromagnetic fields. Int J Robotics Res 25:527–536CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Kurzweil Technologies, Inc.WellesleyUSA
  2. 2.Frontier Medical InstituteDenverUSA

Personalised recommendations